Poletti Michele, Raballo Andrea
Department of Mental Health and Pathological Addiction, Child and Adolescent Neuropsychiatry Service, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Chair of Psychiatry, Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland; Public Health Division, Department of Health and Social Care, Cantonal Socio-Psychiatric Organization, Repubblica e Cantone Ticino, Mendrisio, Switzerland.
Schizophr Res. 2024 Dec;274:189-198. doi: 10.1016/j.schres.2024.09.019. Epub 2024 Sep 27.
Schizophrenia spectrum disorders (SSD) typically have a diagnostically recognizable onset in young adulthood, yet it is not unusual that help-seeking due to initial SSD-related clinical manifestations emerge in earlier developmental phases, such as childhood and adolescence. Varieties of SSD manifestations in children and adolescents can be distinguished according to variations in clinical expressivity, severity and timing (i.e. developmental stage). Some individuals may reach the full clinical threshold for a diagnosis of schizophrenia according to the same descriptive diagnostic criteria used for adults, and in this case, it's possible to distinguish a pre-pubertal onset in childhood (aka Very Early Onset Schizophrenia, VEOS) and a post-pubertal onset in adolescence (aka Early Onset Schizophrenia, EOS). Other individuals may not reach such clinically overt diagnostic threshold but nonetheless present Childhood Schizotypal Disorder (CSD) or a Clinical High-Risk for Psychosis (CHRP). While EOS is clinically more similar to the canonical adult-onset presentation, the other 3 subgroups (i.e. VEOS, CSD, CHRP) present more nuances and specific clinical characteristics, which require ad-hoc developmental and phenomenological considerations for appropriate differential diagnosis and prognosis. Therefore, current scoping review intends to saturate such knowledge gap with respect to early SSD-phenotypes.
精神分裂症谱系障碍(SSD)通常在成年早期有可诊断识别的起病,但因最初与SSD相关的临床表现而寻求帮助在更早的发育阶段出现并不罕见,如儿童期和青少年期。儿童和青少年中SSD的各种表现可根据临床表达、严重程度和时间(即发育阶段)的差异来区分。根据用于成人的相同描述性诊断标准,一些个体可能达到精神分裂症诊断的完全临床阈值,在这种情况下,可以区分儿童期青春期前起病(即极早发性精神分裂症,VEOS)和青少年期青春期后起病(即早发性精神分裂症,EOS)。其他个体可能未达到如此明显的临床诊断阈值,但仍表现为儿童分裂型障碍(CSD)或精神病临床高危状态(CHRP)。虽然EOS在临床上与典型的成人起病表现更相似,但其他3个亚组(即VEOS、CSD、CHRP)呈现出更多细微差别和特定临床特征,这需要特殊的发育和现象学考量以进行适当的鉴别诊断和预后评估。因此,当前的范围综述旨在填补关于早期SSD表型的此类知识空白。